Here’s
an interesting article about the use of apixaban to prevent venous thromboembolism
in patients with various cancers. It came to be via the Facebook BMT and
Hematological Malignancy Interest Group which up to now hasn’t been that
active.
Is it perking up? Let’s hope so…